Changes in antioxidant status associated with haemodialysis in chronic kidney disease

Adeyemi Ogunleye1, Akinwumi A Akinbodewa2, Oluseyi A Adejumo2

  • 1Department of Chemical Pathology, Kidney Care Centre, Ondo, Ondo State, Nigeria.

Ghana Medical Journal
|July 18, 2018
PubMed

Insights

Hemodialysis (HD) significantly reduces total antioxidant capacity (TAC) in chronic kidney disease (CKD) patients after one session. However, HD did not affect malondialdehyde (MDA) levels, a marker of lipid peroxidation.

Area of Science:

  • Nephrology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Oxidative stress is implicated in chronic kidney disease (CKD) pathogenesis and cardiovascular complications.
  • Hemodialysis (HD) may contribute to oxidative stress in CKD patients, but findings are conflicting.

Purpose of the Study:

  • To evaluate the impact of a single HD session on antioxidant capacity and lipid peroxidation in CKD patients.
  • To investigate changes in total antioxidant capacity (TAC) and malondialdehyde (MDA) levels post-HD.

Main Methods:

  • Thirty-six HD-naïve CKD patients underwent a three-hour HD session using polysulfone dialyzers.
  • Blood samples were collected pre- and post-HD.
  • TAC was measured using FRAP assay, and MDA was measured using TBARS assay.

Main Results:

  • A significant decrease in mean TAC was observed post-HD (p<0.001).
  • Malondialdehyde (MDA) levels remained unchanged before and after HD (p>0.05).
  • No association was found between changes in antioxidant status and HD parameters like blood flow rate or ultrafiltration volume.

Conclusions:

  • One session of HD significantly reduces total antioxidant capacity in CKD patients.
  • HD has no significant effect on MDA levels, indicating no increase in lipid peroxidation during the session.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
742
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
673
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
481
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
401
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K